Investor resources
Key reports and regulatory filings.
Corporate Governance
Policies and principles that guide RadNet’s leadership.
Latest News
News & events
RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges
RadNet, Inc. Announces Date of its Third Quarter 2026 Financial Results Conference Call
RadNet, Inc. Announces Agreement to Acquire ONRAD, Inc.
RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals
RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026
RadNet, Inc. to Present at the Jefferies Healthcare Services and Technology Conference on September 15, 2026
RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges
RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call
DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite
RadNet Secures $250 Million Incremental Term Loan to Fund Strategic Growth Opportunities and Reduces the Interest Rates on its Credit Facility by 0.25%
DeepHealth Launches Reporting Pro, Bringing AI Automation to Radiology Reporting
RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities
From the CFO
A CFO’s view of the road ahead.
Our Executive Vice President and Chief Financial Officer on building the future of patient care — filmed at RSNA 2025 in Chicago.
Corporate Governance
Board of Directors
Howard G. Berger, M.D.
Greg Sorensen, M.D.
David Swartz
Larry Levitt
Laura Jacobs
Gregory E. Spurlock
RadNet at a Glance
By the Numbers
$2.04B
revenue
FY 2025
439
imaging centers
as of 10/31/26
11
states
as of 10/31/26
12,000+
employees
as of 10/31/26
1,000+
contracted radiologists
as of 10/31/26
12M+
imaging procedures annually across the RadNet network
as of 06/30/26
2,800+
DeepHealth customers worldwide
as of 6/30/26
53
DeepHealth FDA clearances and CE markings, combined
as of 08/10/26
Analyst coverage
The analysts listed follow RadNet, Inc. Any opinions, estimates or forecasts they publish are their own and do not represent the views of RadNet, Inc. or its management. RadNet does not, by reference or distribution, imply endorsement of or concurrence with their information, conclusions or recommendations.
Jefferies & Company
Analyst: Brian Tanquilut 615-963-8338
Barclays
Analyst: Andrew Mok 212-526-5496
Raymond James & Associates
Analyst: John W. Ransom 727-567-2593
Truist Securities
Analyst: David MacDonald 617-646-5033
Sidoti & Company, LLC
Analyst: Jim Sidoti 212-453-7056
CJS Securities
Analyst: Larry Solow 914-287-7600
B. Riley Securities, Inc.
Analyst: Yuan Zhi, PhD 703-312-1776
KeyBanc Capital Markets
Analyst: Matthew Gillmor 216-471-3506
Stay Current
Investor updates and opportunities.
Complete this form to be added to the distribution list for RadNet press releases.